Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals-Reference-Cited by-同舟云学术

Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals

Published:2018-03-14 Issue:1 Volume:16 Page:
ISSN:1741-7015
Container-title:BMC Medicine
language:en
Short-container-title:BMC Med

Author:

Nordestgaard Liv Tybjærg,Tybjærg-Hansen Anne,Rasmussen Katrine Laura,Nordestgaard Børge G.,Frikke-Schmidt Ruth

Funder

Det Frie Forskningsråd

Lundbeckfonden

Region Hovedstaden

Københavns Universitet

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12916-018-1029-3.pdf

Reference36 articles.

1. Reitz C. Dyslipidemia and the risk of Alzheimer’s disease. Curr Atheroscler Rep. 2013;15:1–14.

2. Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet. 2013;45:1452–8.

3. Corder E, Saunders A, Strittmatter W, Schmechel D, Gaskell P, Small G, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 1993;261:921–3.

4. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet. 2009;41:1088–93.

5. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet. 2009;41:1094–9.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding the Genetic Comorbidity Network of Alzheimer's Disease;2024-08-30

2. Alzheimer's Disease Investigated via Gene-Environment Interactions, Biochemical Pathways, Cellular Processes, and Disease Phenotype Variability;2024-05-14

3. Unraveling the Genetic Comorbidity Landscape of Alzheimer’s Disease;2024-03-08

4. Feasibility of Identifying Factors Related to Alzheimer’s Disease and Related Dementia in Real-World Data;2024-02-13

5. Neuron-targeted exosome therapy: A novel approach for treating cardiogenic dementia via RyR2 inhibition;Medical Hypotheses;2024-02